• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树突状细胞-肿瘤细胞杂交瘤的融合晚期内吞小室与免疫刺激能力。

Fused late endocytic compartments and immunostimulatory capacity of dendritic-tumor cell hybridomas.

作者信息

Gabrijel Mateja, Bergant Martina, Kreft Marko, Jeras Matjaz, Zorec Robert

机构信息

Laboratory of Neuroendocrinology-Molecular Cell Physiology, Institute of Pathophysiology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.

出版信息

J Membr Biol. 2009 May;229(1):11-8. doi: 10.1007/s00232-009-9171-7. Epub 2009 May 6.

DOI:10.1007/s00232-009-9171-7
PMID:19418087
Abstract

Late endocytic compartments, containing MHC class II molecules in antigen presenting cells, fuse to each other in order to deliver antigens to these molecules. We have shown previously that fusion of late endocytic compartments takes place also in hybridomas. Therefore, we investigate here whether the level of fused late endocytic compartments affects the immunostimulatory capacity of hybridomas obtained by the electrofusion of dendritic and tumor cells. The level of fused late endocytic compartments in a single hybridoma cell was assessed and samples of electrofused cells were then cocultured with autologous T cells, resulting in the priming of naïve T cells. To test the immunostimulatory capacity of hybridoma cells, T-cell-induced cytotoxicity of tumor cells was assayed. The results demonstrate that in vitro cytotoxic T cell responses are enhanced if a higher percentage of fused late endocytic compartments is present in the cell population of electrofused hybridoma cells.

摘要

在抗原呈递细胞中,含有II类主要组织相容性复合体分子的晚期内吞区室相互融合,以便将抗原递送至这些分子。我们之前已经表明,晚期内吞区室的融合也发生在杂交瘤中。因此,我们在此研究晚期内吞区室的融合水平是否会影响通过树突状细胞与肿瘤细胞电融合获得的杂交瘤的免疫刺激能力。评估单个杂交瘤细胞中晚期内吞区室的融合水平,然后将电融合细胞样本与自体T细胞共培养,从而启动幼稚T细胞。为了测试杂交瘤细胞的免疫刺激能力,检测了T细胞诱导的肿瘤细胞毒性。结果表明,如果电融合杂交瘤细胞群体中存在更高百分比的融合晚期内吞区室,则体外细胞毒性T细胞反应会增强。

相似文献

1
Fused late endocytic compartments and immunostimulatory capacity of dendritic-tumor cell hybridomas.树突状细胞-肿瘤细胞杂交瘤的融合晚期内吞小室与免疫刺激能力。
J Membr Biol. 2009 May;229(1):11-8. doi: 10.1007/s00232-009-9171-7. Epub 2009 May 6.
2
Monitoring lysosomal fusion in electrofused hybridoma cells.监测电融合杂交瘤细胞中的溶酶体融合。
Biochim Biophys Acta. 2008 Feb;1778(2):483-90. doi: 10.1016/j.bbamem.2007.10.013. Epub 2007 Oct 23.
3
In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids.体外树突状细胞诱导的T细胞对B细胞慢性淋巴细胞白血病的反应因白细胞介素-15和树突状细胞-B-慢性淋巴细胞白血病电融合杂交细胞而增强。
Clin Exp Immunol. 2003 Jan;131(1):82-9. doi: 10.1046/j.1365-2249.2003.02047.x.
4
Endogenous and exogenous forms of the same antigen are processed from different pools to bind MHC class II molecules in endocytic compartments.同一抗原的内源性和外源性形式从不同的库中进行加工,以便在内吞小室中与MHC II类分子结合。
Eur J Immunol. 1999 Jan;29(1):119-31. doi: 10.1002/(SICI)1521-4141(199901)29:01<119::AID-IMMU119>3.0.CO;2-O.
5
Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.内化抗原在树突状细胞中向胞质溶胶的选择性转运以进行MHC I类呈递。
Nat Cell Biol. 1999 Oct;1(6):362-8. doi: 10.1038/14058.
6
Infection Impairs MHC-I Intracellular Trafficking and Antigen Cross-Presentation by Dendritic Cells.感染会损害树突状细胞的 MHC-I 细胞内转运和抗原交叉呈递。
Front Immunol. 2021 Apr 15;12:662096. doi: 10.3389/fimmu.2021.662096. eCollection 2021.
7
Mature dendritic cells use endocytic receptors to capture and present antigens.成熟树突状细胞利用内吞受体捕获和呈递抗原。
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4287-92. doi: 10.1073/pnas.0910609107. Epub 2010 Feb 8.
8
Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.MHC I 类分子在内吞体中的再循环:非专业抗原提呈细胞和树突状细胞。
Front Immunol. 2019 Jan 7;9:3098. doi: 10.3389/fimmu.2018.03098. eCollection 2018.
9
Role of the major histocompatibility complex class II transmembrane region in antigen presentation and intracellular trafficking.主要组织相容性复合体II类跨膜区在抗原呈递和细胞内运输中的作用。
Immunology. 2004 Feb;111(2):165-72. doi: 10.1111/j.0019-2805.2003.01772.x.
10
Differential use of autophagy by primary dendritic cells specialized in cross-presentation.擅长交叉呈递的初级树突状细胞对自噬的差异性利用。
Autophagy. 2015;11(6):906-17. doi: 10.1080/15548627.2015.1045178.

引用本文的文献

1
Potential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer.基于个性化树突状细胞的免疫杂交瘤疫苗治疗前列腺癌的潜力。
Life (Basel). 2023 Jul 1;13(7):1498. doi: 10.3390/life13071498.
2
Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number.基于树突状细胞的疫苗可延长患者的生存时间和下一次治疗的时间,与疫苗细胞数量无关。
Biol Direct. 2022 Feb 23;17(1):5. doi: 10.1186/s13062-022-00318-w.
3
Dielectric analysis and multi-cell electrofusion of the yeast Pichia pastoris for electrophysiological studies.

本文引用的文献

1
Monitoring lysosomal fusion in electrofused hybridoma cells.监测电融合杂交瘤细胞中的溶酶体融合。
Biochim Biophys Acta. 2008 Feb;1778(2):483-90. doi: 10.1016/j.bbamem.2007.10.013. Epub 2007 Oct 23.
2
Preparation of native and amplified tumour RNA for dendritic cell transfection and generation of in vitro anti-tumour CTL responses.用于树突状细胞转染及体外抗肿瘤细胞毒性T淋巴细胞反应生成的天然和扩增肿瘤RNA的制备
Immunobiology. 2006;211(3):179-89. doi: 10.1016/j.imbio.2005.08.008. Epub 2006 Feb 7.
3
Dendritic cell fusion vaccines for cancer immunotherapy.
酵母毕赤酵母的介电分析和多细胞电融合用于电生理研究。
J Membr Biol. 2012 Dec;245(12):815-26. doi: 10.1007/s00232-012-9484-9. Epub 2012 Aug 8.
4
Cell-cell electrofusion: optimization of electric field amplitude and hypotonic treatment for mouse melanoma (B16-F1) and Chinese Hamster ovary (CHO) cells.细胞-细胞电融合:优化电场幅度和低渗处理对小鼠黑色素瘤(B16-F1)和中国仓鼠卵巢(CHO)细胞的影响。
J Membr Biol. 2010 Jul;236(1):107-16. doi: 10.1007/s00232-010-9272-3. Epub 2010 Jul 14.
5
Induction/engineering, detection, selection, and expansion of clinical-grade human antigen-specific CD8 cytotoxic T cell clones for adoptive immunotherapy.用于过继性免疫治疗的临床级人抗原特异性CD8细胞毒性T细胞克隆的诱导/工程化、检测、筛选及扩增。
J Biomed Biotechnol. 2010;2010:705215. doi: 10.1155/2010/705215. Epub 2010 Mar 10.
用于癌症免疫治疗的树突状细胞融合疫苗。
Expert Opin Biol Ther. 2005 May;5(5):703-15. doi: 10.1517/14712598.5.5.703.
4
Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate.抗原呈递细胞中溶酶体蛋白水解的差异决定了抗原的命运。
Science. 2005 Mar 11;307(5715):1630-4. doi: 10.1126/science.1108003.
5
Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application.通过电融合产生树突状细胞-肿瘤细胞杂交体用于临床疫苗应用。
Cancer Immunol Immunother. 2004 Aug;53(8):705-14. doi: 10.1007/s00262-004-0512-1. Epub 2004 Mar 26.
6
Automated high through-put colocalization analysis of multichannel confocal images.多通道共聚焦图像的自动化高通量共定位分析。
Comput Methods Programs Biomed. 2004 Apr;74(1):63-7. doi: 10.1016/S0169-2607(03)00071-3.
7
Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination.诱导针对急性髓系白血病衍生抗原的细胞毒性T淋巴细胞:评估树突状细胞-白血病细胞杂交体及其他基于树突状细胞疫苗接种的抗原加载策略。
Cancer Immunol Immunother. 2002 Aug;51(6):299-310. doi: 10.1007/s00262-002-0284-4. Epub 2002 Jun 14.
8
Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.用于树突状细胞抗原负载以增强抗肿瘤免疫反应的策略。
Cancer Res. 2002 Mar 15;62(6):1884-9.
9
Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis.MHC II类分子上细胞溶质和内源性跨膜蛋白抗原的有效呈递依赖于细胞质蛋白水解。
J Immunol. 2001 Sep 1;167(5):2632-41. doi: 10.4049/jimmunol.167.5.2632.
10
Antigen processing for amateurs and professionals.面向初学者和专业人士的抗原加工
Trends Cell Biol. 1998 Jun;8(6):231-7. doi: 10.1016/s0962-8924(98)01276-8.